Suppr超能文献

男性乳腺癌:病理及免疫组化特征

Male breast cancer: pathological and immunohistochemical features.

作者信息

Willsher P C, Leach I H, Ellis I O, Bell J A, Elston C W, Bourke J B, Blamey R W, Robertson J F

机构信息

Professorial Unit of Surgery, City Hospital, Nottingham, UK.

出版信息

Anticancer Res. 1997 May-Jun;17(3C):2335-8.

PMID:9245247
Abstract

BACKGROUND

male breast cancer is uncommon and studies regarding the potential clinical relevance of the histopathological and immunohistochemical features are infrequently reported.

MATERIALS AND METHODS

We investigated the biological characteristics of forty-one male patients with invasive breast cancer by assessing histopathological and multiple immunohistochemical features.

RESULTS

The majority were no special type (ductal) (37/41), lobular cancer was not seen. 73% were histological grade 3, 93% were positive for oestrogen receptor and 73% for progesterone receptor. The proportion of cancers positive for c-ebB-2 (45%), EGFR (20%), p53 (58%), MiB1 (40%), NCRC11 (78%), were similar to reports for female breast cancer. Nonsignificant associations between poor survival outcome and grade 3 tumours, and positive tissue staining for MiB1 and p53 were seen.

CONCLUSION

While there ar similarities in the biological features of breast cancer in males and females, some differences were identified. Male breast cancer is more likely to be grade 3 tumours and hormone receptor positive.

摘要

背景

男性乳腺癌并不常见,关于其组织病理学和免疫组化特征潜在临床相关性的研究报道较少。

材料与方法

我们通过评估组织病理学和多种免疫组化特征,对41例浸润性乳腺癌男性患者的生物学特性进行了研究。

结果

大多数为非特殊类型(导管癌)(37/41),未发现小叶癌。73%为组织学3级,93%雌激素受体阳性,73%孕激素受体阳性。c-ebB-2(45%)、表皮生长因子受体(EGFR,20%)、p53(58%)、增殖细胞核抗原(MiB1,40%)、NCRC11(78%)阳性的癌症比例与女性乳腺癌的报道相似。在生存预后不良与3级肿瘤以及MiB1和p53组织染色阳性之间未发现显著关联。

结论

虽然男性和女性乳腺癌的生物学特征存在相似之处,但也发现了一些差异。男性乳腺癌更可能是3级肿瘤且激素受体阳性。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验